Qi

Qi Health Revolutionizes Women's Health with Evidence-Based Chinese Herbal Medicine

Retrieved on: 
Monday, November 27, 2023

Qi Health introduces the first evidence-based digital health platform for herbal medicine, revolutionizing women's well-being with natural solutions.

Key Points: 
  • New York, New York--(Newsfile Corp. - November 27, 2023) - Qi Health , a cutting-edge digital health platform dedicated to Chinese Herbal Medicine (CHM) emerges from beta today.
  • By connecting patients with certified Traditional Chinese Medicine (TCM) doctors in the United States through video calls, Qi Health brings a transformative approach to women's healthcare.
  • In a world where Traditional Chinese Medicine often faces skepticism, Qi Health relies on rigorous research and evidence-based care.
  • Qi Health's vision extends beyond individual care; it aspires to make Traditional Chinese Herbal Medicine accessible to everyone with unexplained or untreated health issues.

Flash News: OKX Wallet Partners with BENQI, Giving Users an APR Boost of Up to 7%

Retrieved on: 
Wednesday, December 20, 2023

SINGAPORE, Dec. 20, 2023 (GLOBE NEWSWIRE) -- OKX , a leading Web3 technology company, has issued updates for December 20, 2023.

Key Points: 
  • SINGAPORE, Dec. 20, 2023 (GLOBE NEWSWIRE) -- OKX , a leading Web3 technology company, has issued updates for December 20, 2023.
  • OKX Wallet Partners with BENQI, Giving Users an APR Boost of Up to 7%
    OKX Wallet partnered with BENQI offering users who stake AVAX with BENQI, the opportunity to earn up to 7% in APR boost on OKX DeFi - in addition to any base APR.
  • The BENQI Bonus event started on December 19 and will last until March 18, 2024 with a bonus pool of 5,000,000 Qi.
  • OKX DeFi is a powerful DeFi platform that supports earning and staking on about 70 protocols across more than 10 chains.

Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US

Retrieved on: 
Monday, December 18, 2023

In April 2023, Avalon announced that it has partnered with Qi Diagnostics to exclusively distribute the KetoAir™ in North America, South America, the UK and the EU.

Key Points: 
  • In April 2023, Avalon announced that it has partnered with Qi Diagnostics to exclusively distribute the KetoAir™ in North America, South America, the UK and the EU.
  • KetoAir™ functions as a companion diagnostic and monitoring device, combined with an artificial intelligence (AI) nutritionist consultation for ketogenic dietary management (United States FDA registration number: 3026284320).
  • “We are excited to partner with ChtrBx to create a successful marketing plan to launch KetoAir™ in the U.S. and abroad,” commented David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon.
  • We plan to soft launch KetoAir™ in 2024 followed by a hard launch in 2025.”

Wistar Scientists Identify Esophageal Cancer Biomarkers

Retrieved on: 
Wednesday, December 6, 2023

Philadelphia, PA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology.

Key Points: 
  • Philadelphia, PA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology.
  • Under the leadership of Dr. Noam Auslander — assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular & Cellular Oncogenesis Program — the group has analyzed short read RNA-sequencing data to detect biomarkers for esophageal carcinoma, or ESCA.
  • Since 1972, the Institute has held National Cancer Institute (NCI)-designated Cancer Center status.
  • Wistar scientists are dedicated to solving some of the world’s most challenging problems in the field of cancer and immunology, advancing human health through early-stage discovery and training the next generation of biomedical researchers.

Qi v2.0 Standard for Wireless Charging Is Now Ready to Provide Enhanced User Experience

Retrieved on: 
Wednesday, November 15, 2023

The Wireless Power Consortium’s (WPC) next generation standard for wireless charging, Qi v2.0 , will soon be delivering on its promise of magnetic attachment, faster charging, higher efficiency and greater convenience as the first Qi2 mobile devices complete certification testing.

Key Points: 
  • The Wireless Power Consortium’s (WPC) next generation standard for wireless charging, Qi v2.0 , will soon be delivering on its promise of magnetic attachment, faster charging, higher efficiency and greater convenience as the first Qi2 mobile devices complete certification testing.
  • In addition to an enhanced user experience, Qi v2.0 unifies the industry under one global standard.
  • The first Qi v2.0 Certified products will be available in time for the holiday season starting with Apple’s iPhone 15 lineup and a host of power transmitters.
  • New Qi v2.0 EPP products will be branded with the existing Qi logo consumers know and use today.

Intriguing Facts about Confucius

Retrieved on: 
Wednesday, December 6, 2023

BEIJING, Dec. 6, 2023 /PRNewswire/ -- A news report from China.org.cn on the short and unsuccessful political career of Confucius:

Key Points: 
  • BEIJING, Dec. 6, 2023 /PRNewswire/ -- A news report from China.org.cn on the short and unsuccessful political career of Confucius:
    The political career of Confucius is quite short.
  • During his tenure, all the nearby rulers took note of Confucius.
  • Confucius was thwarted in Lu by a stratagem of the Duke of Qi.
  • In 496 B. C. Confucius was disappointed and quitted service.

Signia Silk Charge&Go IX Hearing Aid is Selected as a 2024 CES Innovation Awards Best of Innovation Honoree

Retrieved on: 
Wednesday, November 22, 2023

ISELIN, N.J., Nov. 22, 2023 /PRNewswire/ -- Hearing aid innovator Signia has been named a Best of Innovation honoree in the 2024 CES Innovation Awards for its Signia Silk Charge&Go IX hearing aid, which provides unprecedented sound clarity and definition for wearers in noisy group conversations – even when the wearer or speakers are in motion. The recognition underscores the company's commitment to delivering innovative hearing technology to all hearing aid wearers in every scenario.

Key Points: 
  • ISELIN, N.J., Nov. 22, 2023 /PRNewswire/ -- Hearing aid innovator Signia has been named a Best of Innovation honoree in the 2024 CES Innovation Awards for its Signia Silk Charge&Go IX hearing aid, which provides unprecedented sound clarity and definition for wearers in noisy group conversations – even when the wearer or speakers are in motion.
  • The recognition underscores the company's commitment to delivering innovative hearing technology to all hearing aid wearers in every scenario.
  • The CES Innovation Awards recognize brands that drive innovation with outstanding design and engineering in consumer technology products across technology verticals.
  • The new Signia Silk Charge&Go IX hearing aid – one of two hearing aids to debut Signia's industry-leading Integrated Xperience (IX) technology in September 2023 – was recognized in the Wearable Technologies category.

East China's Shandong: a fertile land of humanity brimming with renewed traditions

Retrieved on: 
Thursday, November 9, 2023

Nowadays, the province is promoting the creative transformation of excellent traditional Chinese culture, revitalizing time-honored traditions on the fertile land of humanity.

Key Points: 
  • Nowadays, the province is promoting the creative transformation of excellent traditional Chinese culture, revitalizing time-honored traditions on the fertile land of humanity.
  • Shandong is the hometown of the ancient Chinese philosophers Confucius and Mencius, and culture is nurturing everything subtly like water.
  • Jining City, the important birthplace and inheritance hub of Confucianism, is also a key part of the Grand Canal culture.
  • For friends who enjoy exploring the world, it's worth visiting Shandong to taste its charm, cuisine and culture.

Launchpad Technologies Recognized as a 2023 Deloitte Technology Fast 50™ Program Company

Retrieved on: 
Wednesday, November 8, 2023

VANCOUVER, BC, Nov. 8, 2023 /PRNewswire/ - Launchpad Technologies Inc. ("Launchpad") received recognition as part of the 2023 Deloitte Technology Fast 50™ award program for its rapid revenue growth, entrepreneurial spirit, and bold innovation.

Key Points: 
  • VANCOUVER, BC, Nov. 8, 2023 /PRNewswire/ - Launchpad Technologies Inc. ("Launchpad") received recognition as part of the 2023 Deloitte Technology Fast 50™ award program for its rapid revenue growth, entrepreneurial spirit, and bold innovation.
  • Celebrating its 26th anniversary, the program recognizes Canada's 50 fastest-growing technology companies based on the highest revenue-growth percentage over the past four years.
  • The Deloitte Technology Fast 50 program winners consist of public and private companies in the technology sector that are transforming the industry.
  • The program runs alongside the broader Deloitte North American Technology Fast 500™, with winners automatically eligible for this elite ranking.

Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis

Retrieved on: 
Wednesday, October 18, 2023

DKA is a serious complication of diabetes that can be life-threatening. DKA is most common among children with Type 1 diabetes, however adults with Type 2 diabetes can also develop DKA. DKA occurs when the insulin level drops rapidly and can’t drive blood sugar into the cells for use as fuel supply. Under this condition, the liver starts to break down fat for energy -- a process that generates acidic substances called ketones, which can accumulate to dangerous levels in the body. Acetone is a volatile ketone which can be detected in the breath. If left untreated, DKA can escalate within 24 hours into life-threatening conditions such as brain swelling, cardiac arrest, kidney damage, coma and death.

Key Points: 
  • FREEHOLD, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced that it has partnered with Qi Diagnostics Limited (“Qi Diagnostics”) to co-develop international multi-center clinical studies for DKAir™ breathalyzer device for the early detection of diabetic ketoacidosis (“DKA”).
  • Qi Diagnostics has developed DKAir™ a handheld breathalyzer that allows diabetic patients to blow into the breathalyzer to detect the acetone levels in their breath.
  • We are excited to partner with Qi Diagnostics to co-develop international multi-center clinical studies for DKAir™.
  • The preclinical research has been completed and we expect the clinical studies to start in the first quarter of 2024.”